Novartis AG
NVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11,459,000 | $13,393,000 | $7,517,000 | $12,407,000 |
| Short-Term Investments | $1,892,000 | $569,000 | $11,098,000 | $15,706,000 |
| Receivables | $8,211,000 | $9,376,000 | $9,894,000 | $9,621,000 |
| Inventory | $5,723,000 | $5,913,000 | $7,175,000 | $6,666,000 |
| Other Curr. Assets | $2,419,000 | $1,230,000 | $1,226,000 | $1,318,000 |
| Total Curr. Assets | $29,704,000 | $30,481,000 | $36,910,000 | $45,718,000 |
| Property Plant & Equip (Net) | $10,873,000 | $10,924,000 | $12,195,000 | $13,106,000 |
| Goodwill | $24,756,000 | $23,341,000 | $29,301,000 | $29,595,000 |
| Intangibles | $26,915,000 | $26,879,000 | $31,644,000 | $34,182,000 |
| Long-Term Investments | $1,128,000 | $1,827,000 | $1,606,000 | $2,268,000 |
| Tax Assets | $4,359,000 | $4,309,000 | $3,739,000 | $3,743,000 |
| Other NC Assets | $4,511,000 | $2,184,000 | $2,058,000 | $3,183,000 |
| Total NC Assets | $72,542,000 | $69,464,000 | $80,543,000 | $86,077,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $102,246,000 | $99,945,000 | $117,453,000 | $131,795,000 |
| Liabilities | – | – | – | – |
| Payables | $4,572,000 | $4,926,000 | $5,146,000 | $5,553,000 |
| Short-Term Debt | $8,324,000 | $6,314,000 | $6,127,000 | $6,502,000 |
| Tax Payable | $2,225,000 | $2,409,000 | $3,369,000 | $3,034,000 |
| Deferred Revenue | $127,000 | $98,000 | $123,000 | $123,000 |
| Other Curr. Liab. | $13,444,000 | $12,643,000 | $13,891,000 | $14,996,000 |
| Total Curr. Liab. | $28,692,000 | $26,390,000 | $28,656,000 | $30,208,000 |
| LT Debt | $22,934,000 | $20,034,000 | $21,782,000 | $24,523,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2,419,000 | $2,248,000 | $2,686,000 | $3,070,000 |
| Other NC Liab. | $4,075,000 | $4,523,000 | $4,906,000 | $6,172,000 |
| Total NC Liab. | $29,428,000 | $26,805,000 | $29,374,000 | $33,765,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,803,000 | $1,828,000 | $1,789,000 | $1,896,000 |
| Total Liabilities | $58,120,000 | $53,195,000 | $58,030,000 | $63,973,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $793,000 | $825,000 | $890,000 | $901,000 |
| Retained Earnings | $46,561,000 | $49,649,000 | $63,540,000 | $70,989,000 |
| AOCI | -$3,255,000 | -$3,766,000 | -$4,996,000 | -$4,187,000 |
| Other Equity | -$53,000 | -$41,000 | -$92,000 | -$48,000 |
| Total Equity | $44,046,000 | $46,667,000 | $59,342,000 | $67,655,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $80,000 | $83,000 | $81,000 | $167,000 |
| Total Liab. & Tot. Equity | $102,246,000 | $99,945,000 | $117,453,000 | $131,795,000 |
| Net Debt | $19,799,000 | $12,955,000 | $20,392,000 | $18,618,000 |